Isolated angioedema: A review of classification and update on management
- PMID: 35988876
- DOI: 10.1016/j.anai.2022.08.003
Isolated angioedema: A review of classification and update on management
Abstract
Objective: To review the various types of angioedema including diagnosis and treatment.
Data sources: PubMed search of articles in the English language of various types of angioedema.
Study selections: Articles on the subject matter were selected and reviewed.
Results: Herein, a case-based approach is presented for discussing the major types of angioedema, including the following: hereditary angioedema types I and II and normal complement, acquired angioedema, angiotensin-converting enzyme-induced angioedema, and histaminergic and nonhistaminergic angioedema. Emerging treatments of hereditary angioedema including targets of prekallikrein, DNA vector technology replacing C1-INH protein, and CRIPSR technology targeting prekallikrein among many others are explored. In addition, other causes and mimickers of angioedema are briefly reviewed. Finally, a novel algorithm is proposed to help guide the treating physician through the workup and management of patients with suspected idiopathic angioedema unresponsive to conventional therapy with antihistamines.
Conclusion: Over the years, many strides have been made in both understanding the pathophysiology of various types of angioedema and expansion of treatment options. It is important for clinicians to be aware of current and emerging treatment options. We provide a novel practical algorithm to guide clinicians in challenging cases of idiopathic angioedema refractory to antihistamines.
Copyright © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.Ann Med. 2016;48(4):256-67. doi: 10.3109/07853890.2016.1162909. Epub 2016 Mar 26. Ann Med. 2016. PMID: 27018196 Review.
-
Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.Clin Rev Allergy Immunol. 2016 Oct;51(2):207-15. doi: 10.1007/s12016-016-8555-6. Clin Rev Allergy Immunol. 2016. PMID: 27273087 Review.
-
Angioedema without wheals: a clinical update.Balkan Med J. 2021 Mar;38(2):73-81. doi: 10.5152/balkanmedj.2021.20060. Balkan Med J. 2021. PMID: 33593719 Free PMC article.
-
Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.Int Arch Allergy Immunol. 2014;165(2):119-27. doi: 10.1159/000368404. Epub 2014 Nov 15. Int Arch Allergy Immunol. 2014. PMID: 25401373
-
[Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].Ann Dermatol Venereol. 2018 Oct;145(10):598-602. doi: 10.1016/j.annder.2018.02.012. Epub 2018 Apr 17. Ann Dermatol Venereol. 2018. PMID: 29673745 French.
Cited by
-
Hong Kong-Macau Severe Hives and Angioedema Referral Pathway.Front Allergy. 2023 Dec 6;4:1290021. doi: 10.3389/falgy.2023.1290021. eCollection 2023. Front Allergy. 2023. PMID: 38125294 Free PMC article.
-
Pseudo-Allergies in the Emergency Department: A Common Misdiagnosis of Hypersensitivity Type 1 Allergic Reaction.Cureus. 2023 Oct 5;15(10):e46536. doi: 10.7759/cureus.46536. eCollection 2023 Oct. Cureus. 2023. PMID: 37927771 Free PMC article. Review.
-
Risperidone-induced angioedema.Ment Health Clin. 2024 Oct 1;14(5):298-301. doi: 10.9740/mhc.2024.10.298. eCollection 2024 Oct. Ment Health Clin. 2024. PMID: 39371487 Free PMC article.
-
Acquired Angioedema in Selected Neoplastic Diseases.Medicina (Kaunas). 2023 Mar 24;59(4):644. doi: 10.3390/medicina59040644. Medicina (Kaunas). 2023. PMID: 37109602 Free PMC article.
-
Lanadelumab for prevention of attacks of non-histaminergic normal C1 inhibitor angioedema: results from the randomized, double-blind CASPIAN Study and CASPIAN open-label extension.Front Immunol. 2025 May 21;16:1502325. doi: 10.3389/fimmu.2025.1502325. eCollection 2025. Front Immunol. 2025. PMID: 40469312 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources